(Q33787152)

29 July 2017

1 reference

title

Statins and dilated cardiomyopathy: do we have enough data? (English)

1 reference

29 July 2017

main subject

dilated cardiomyopathy

1 reference

based on heuristic

inferred from title

author

Dimitri P Mikhailidis

series ordinal

2

object named as

Dimitri P Mikhailidis

1 reference

29 July 2017

6

Maciej Banach

1 reference

29 July 2017

Agata Bielecka-Dąbrowa

object named as

Agata Bielecka-Dabrowa

series ordinal

1

0 references

Wilbert S Aronow

series ordinal

4

object named as

Wilbert S Aronow

1 reference

29 July 2017

5

Jacek Rysz

1 reference

29 July 2017

Simon Hannam

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

6 January 2011

1 reference

Expert Opinion on Investigational Drugs

29 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 July 2017

volume

20

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

315-323

1 reference

Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Cytokine-induced modulation of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Cytokine production and antibodies against heat shock protein 60 in cardiomyopathies of different origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

The role of tumor necrosis factor alpha blockade in the treatment of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Statin therapy in the elderly: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Activation of NADPH oxidase during progression of cardiac hypertrophy to failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Role and significance of statins in the treatment of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

A prospective evaluation of the effect of simvastatin on heart rate variability in non-ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

The role of statin therapy in the management of cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Preservation of NO production by statins in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.550570

10.1517/13543784.2011.550570

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference